DLC1 RhoGAP Protein with Tumor Suppressor Function Binds to RASA1 and Modulates RhoA GTPase Activity and Tumor Cell Proliferation

Xu-Yu Yang,Ming Guan,Nicholas C. Popescu

2008-01-01

Abstract:99 DLC1 encodes a Rho GTPase activating protein and functions as a tumor suppressor gene in several major forms of cancer. The multidomain structure of DLC1 suggests that it might interact with a variety of proteins. In addition to RhoGAP, the sterile alpha motif (SAM) and StAR-related lipid transfer (START) domains have also been implicated in protein-protein interactions. In this study a yeast 2-hybrid survey and coimmunoprecipitation identified RASA1 as a new binding partner of DLC1. In human cells, RASA1 interacts and colocalizes with DLC1 in the cell cytoplasm. The binding site was mapped to the DLC1 RhoGAP domain and to the RASA1 SH3 domain. Sequence analysis revealed that the binding to RASA1 is not dependent on the conventional SH3 binding proline-rich (PxxP) consensus sequences. In HCT15, a DLC1 and RASA1-deficient colon carcinoma cell line carrying a Gly12Ser mutation of H-Ras oncogene, ectopic expression of RASA1 augmented cell proliferation, whereas restoration of DLC1 expression had an antagonistic effect. The promotion of cell proliferation by RASA1 was associated with an increase in RhoA activity in vivo. In PC-3 prostate carcinoma cells that express RASA1 but lack DLC1 expression, knocking down RASA1 by siRNA significantly enhanced DLC1-mediated suppression of RhoA activity. These results suggest that DLC1 interaction with RASA1 modulates RhoA activity and cell proliferation thus providing potential targets for therapeutic interventions in cancers carrying with ras mutation.